Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Integrase-Deficient Lentiviral Vector for Efficient CRISPR/Cas9-Mediated Gene and Epigenome-Editing Applications

Publication ,  Conference
Kantor, B; Ilich, E; Tagliafierro, L; Chiba-Falek, O
Published in: MOLECULAR THERAPY
April 22, 2019

Duke Scholars

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

April 22, 2019

Volume

27

Issue

4

Start / End Page

101 / 101

Location

Washington, DC

Publisher

CELL PRESS

Conference Name

22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kantor, B., Ilich, E., Tagliafierro, L., & Chiba-Falek, O. (2019). Integrase-Deficient Lentiviral Vector for Efficient CRISPR/Cas9-Mediated Gene and Epigenome-Editing Applications. In MOLECULAR THERAPY (Vol. 27, pp. 101–101). Washington, DC: CELL PRESS.
Kantor, Boris, Ekaterina Ilich, Lidia Tagliafierro, and Ornit Chiba-Falek. “Integrase-Deficient Lentiviral Vector for Efficient CRISPR/Cas9-Mediated Gene and Epigenome-Editing Applications.” In MOLECULAR THERAPY, 27:101–101. CELL PRESS, 2019.
Kantor B, Ilich E, Tagliafierro L, Chiba-Falek O. Integrase-Deficient Lentiviral Vector for Efficient CRISPR/Cas9-Mediated Gene and Epigenome-Editing Applications. In: MOLECULAR THERAPY. CELL PRESS; 2019. p. 101–101.
Kantor, Boris, et al. “Integrase-Deficient Lentiviral Vector for Efficient CRISPR/Cas9-Mediated Gene and Epigenome-Editing Applications.” MOLECULAR THERAPY, vol. 27, no. 4, CELL PRESS, 2019, pp. 101–101.
Kantor B, Ilich E, Tagliafierro L, Chiba-Falek O. Integrase-Deficient Lentiviral Vector for Efficient CRISPR/Cas9-Mediated Gene and Epigenome-Editing Applications. MOLECULAR THERAPY. CELL PRESS; 2019. p. 101–101.

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

April 22, 2019

Volume

27

Issue

4

Start / End Page

101 / 101

Location

Washington, DC

Publisher

CELL PRESS

Conference Name

22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences